Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.

PloS one - 1 Jan 2015

Yan Hong-Mei, Xia Ming-Feng, Wang Yan, Chang Xin-Xia, Yao Xiu-Zhong, Rao Sheng-Xiang, Zeng Meng-Su, Tu Yin-Fang, Feng Ru, Jia Wei-Ping, Liu Jun, Deng Wei, Jiang Jian-Dong, Gao Xin

Abstract excerpt

OBJECTIVES: A randomized, parallel controlled, open-label clinical trial was conducted to evaluate the effect of a botanic compound berberine (BBR) on NAFLD. METHODS: A randomized, parallel controlled, open-label clinical trial was conducted in three medical centers (NIH Registration number: NCT00633282). A total of 184 eligible patients with NAFLD were enrolled and randomly received (i) lifestyle intervention...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiposity
Share to Administration, Oral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Glucose

Share to Diet, High-Fat

Share to Energy Metabolism

Share to Metabolome

Share to Non-alcoholic Fatty Liver Disease

Share to Rats, Sprague-Dawley

Source

Open in PubMed Open full text

Identifiers

PMID: 26252777
DOI: 10.1371/journal.pone.0134172
PMCID: PMC4529214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.PMID 26252777Read ↗

Unraveling Berberine's Multi-Target Mechanism in Combating NAFLD: A Network Pharmacology and In Vitro StudySemantic proximity Read ↗

Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesSemantic proximity Read ↗

Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty LiverSemantic proximity Read ↗

The Efficacy of Food Bioactive Compounds in The Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds.Semantic proximity Read ↗

Broccoli Leaf Phenolics Ameliorate NAFLD via Regulation of EGFR/AKT/SREBP Signaling Pathways and Gut MicrobiotaSemantic proximity Read ↗

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid OxidationSemantic proximity Read ↗

Exploration of the mechanism of Alisol B in improving NAFLD of L-02 cells under hypoxic through the PI3K/AKT-mTOR-HIF1α signaling pathwaySemantic proximity Read ↗

Ketogenic Diet Ameliorates NAFLD via Balancing Mitochondrial Dynamics and Improving Mitochondrial DysfunctionSemantic proximity Read ↗

Pharmaceutical Strategies to Make Better Drugs for Nonalcoholic Fatty Liver Disease TherapySemantic proximity Read ↗

Dramatic Suppression of Lipogenesis and No Increase in Beta- Oxidation Are the Main Effects of Bergamot Flavonoids on Gene Expression in Fatty Liver DiseaseSemantic proximity Read ↗

Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD ratsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.